(Q53254097)

12 May 2018

title

Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. (English)

1 reference

12 May 2018

0 references

1 reference

8

Jonathan L Halperin

1 reference

12 May 2018

Nanette Wenger

2

object named as

Nanette K Wenger

1 reference

12 May 2018

author name string

Mardi Gomberg-Maitland

1

1 reference

12 May 2018

Jan Feyzi

3

1 reference

12 May 2018

Maria Lengyel

4

1 reference

12 May 2018

Annabelle S Volgman

5

1 reference

12 May 2018

Palle Petersen

6

1 reference

12 May 2018

Lars Frison

7

1 reference

12 May 2018

publication date

14 June 2006

1 reference

12 May 2018

published in

European Heart Journal

1 reference

12 May 2018

volume

27

1 reference

12 May 2018

issue

16

1 reference

12 May 2018

page(s)

1947-1953

1 reference

12 May 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Impact of atrial fibrillation on mortality, stroke, and medical costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Stroke prevention in atrial fibrillation: physicians' attitudes to anticoagulation in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

Hepatic findings in long-term clinical trials of ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHL103

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHL103

1 reference

12 May 2018

1 reference

12 May 2018